Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities

Table 2

Effects of Gal-1 treatment on cardiovascular disease.

Model	Effects	Mechanisms	Reference
AMI (reperfused)	Improved remodeling	Inflammation? (not evaluated)	[19]
Stroke	Improved sensorimotor dysfunction	Increased neurogenesis. No effect on infarct volume	[72]

AMI = acute myocardial infarction; HF = heart failure; PAH = pulmonary arterial hypertension.